Noice Logo
Babbage: A flicker of light for Alzheimer’s

Babbage: A flicker of light for Alzheimer’s

24 Menit

Tandai selesai
Tambah ke Antrean

8 Juni 2021

After almost two decades, the FDA has granted conditional approval to a drug for the treatment of Alzheimer’ disease, called aducanumab. But the new drug, and its approval, is surrounded by controversy. Will the gamble pay off? Also, a clever upgrade to fog-collecting technology which could provide a water source in remote locations. And, potentially life-saving oxygen enemas? Kenneth Cukier hosts  For full access to The Economist’s print, digital and audio editions subscribe at and sign up for our new weekly science newsletter at Hosted on Acast. See for more information.


Lihat episode lain
Buka semua fitur dengan download aplikasi Noice
Kunjungi App